aspirin has been researched along with Infarction, Middle Cerebral Artery in 50 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was carried out to investigate the effect of the combination of an endothelin antagonist TAK-044 and an antiinflammatory agent aspirin in middle cerebral artery (MCA) occlusion model of acute ischemic stroke in rats." | 7.74 | Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats. ( Briyal, S; Gulati, A; Gupta, YK, 2007) |
| "Focal cerebral ischemia was induced by MCA occlusion for 2 hours followed by reperfusion for 22 hours." | 5.37 | Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats. ( Ahmad, SJ; Akhtar, M; Islam, F; Khanam, R; Pillai, KK; Pratap, R, 2011) |
| "A temporary middle cerebral artery occlusion (tMCAO) model was used in 80 Wistar rats to evaluate whether a high dose of Aspirin (40 mg/kg) applied with different initiation time points after stroke onset (30 min, 3 h, 6 h, 12 h, 20 rats for each time group) and followed by repeated administration (1, 2 and 3 days) is neuroprotective." | 5.34 | Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin. ( Berger, C; Grau, A; Schwab, S; Zheng, Z, 2007) |
| "Neurocysticercosis is the most common parasitic infection of the central nervous system." | 5.33 | Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. ( Bouldin, A; Pinter, JD, 2006) |
| "The present study was carried out to investigate the effect of the combination of an endothelin antagonist TAK-044 and an antiinflammatory agent aspirin in middle cerebral artery (MCA) occlusion model of acute ischemic stroke in rats." | 3.74 | Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats. ( Briyal, S; Gulati, A; Gupta, YK, 2007) |
| " Dose-response and therapeutic window were investigated." | 1.72 | Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window. ( Bazan, NG; Belayev, L; Khoutorova, L; Mukherjee, PK; Obenaus, A; Oria, RB; Petasis, NA; Reid, MM; Roque, CR, 2022) |
| "Default of therapy for polycythemia is associated with a profound risk of recurrent strokes requiring patient education and support to prevent the devastating consequence of this modifiable but rare cause of stroke." | 1.51 | Recurrent Stroke in a Ghanaian Patient With Polycythemia. ( Berchie, PO; Opare-Sem, OK; Ovbiagele, B; Sarfo, FS, 2019) |
| "Co-treatment of aspirin and NLCs did not improve the outcome." | 1.48 | Neural like cells and acetyl-salicylic acid alter rat brain structure and function following transient middle cerebral artery occlusion. ( Asadi-Shekaari, M; Nematollahi-Mahani, SN; Shamsara, A; Sheibani, V, 2018) |
| "Nimodipine and aspirin were set as positive control separately." | 1.43 | Sodium Sulfide, a Hydrogen Sulfide-Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats. ( Chen, B; Cheng, MH; Fan, BS; Shi, HQ; Tian, JS; Yu, JG; Zhang, Y, 2016) |
| "Cerebral ischemia was induced for 2 h followed by reperfusion for 22 h." | 1.43 | Protective Effect of Guggulipid in High Fat Diet and Middle Cerebral Artery Occlusion (MCAO) Induced Ischemic Cerebral Injury in Rats. ( Ahmad, MA; Akhtar, M; Mujeeb, M; Najmi, AK, 2016) |
| "Focal cerebral ischemia was induced by MCA occlusion for 2 hours followed by reperfusion for 22 hours." | 1.37 | Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats. ( Ahmad, SJ; Akhtar, M; Islam, F; Khanam, R; Pillai, KK; Pratap, R, 2011) |
| "We report a patient who presented with transient ischemic attack (TIA) associated with stenosis of the accessory MCA ostium." | 1.35 | Transient ischemic attack associated with stenosis of accessory middle cerebral artery: a case report. ( Gao, F; Jiang, WJ, 2009) |
| "We studied 103 patients with MCA stenosis using transcranial Doppler (TCD) and re-evaluated the TCD results at 6 months after the initial investigation and measured platelet aggregability for adenosine diphosphate (ADP) or arachidonic acid (AA)." | 1.35 | Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy. ( Cha, JK; Jeon, HW, 2008) |
| "Neu2000 protected against the effects of middle cerebral artery occlusion, even when delivered 8 h after reperfusion." | 1.34 | Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. ( Ahn, YM; Byun, HY; Cho, JY; Cho, SI; Chung, JM; Gwag, BJ; Im, DS; Kim, KW; Ko, SY; Kwon, HJ; Lee, HU; Lee, JY; Lee, MJ; Lee, YA; Lim, HR; Moon, HS; Noh, JH; Park, SM; Son, SJ; Won, SJ; Yoon, SH; Yun, BS, 2007) |
| "A temporary middle cerebral artery occlusion (tMCAO) model was used in 80 Wistar rats to evaluate whether a high dose of Aspirin (40 mg/kg) applied with different initiation time points after stroke onset (30 min, 3 h, 6 h, 12 h, 20 rats for each time group) and followed by repeated administration (1, 2 and 3 days) is neuroprotective." | 1.34 | Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin. ( Berger, C; Grau, A; Schwab, S; Zheng, Z, 2007) |
| "Acute in-stent thrombosis is a well-known complication of carotid angioplasty and stenting (CAS) and often due to resistance to or inadequate treatment with platelet-inhibiting agents." | 1.33 | Late in-stent thrombosis following carotid angioplasty and stenting. ( Buhk, JH; Knauth, M; Wellmer, A, 2006) |
| "Aspirin therapy was initiated and continued during 2,5 years." | 1.33 | Post-varicella arteriopathy: benefits of using serial transcranial Doppler examinations. ( Boissier, C; Chabrier, S; Rougeot, C, 2006) |
| "Neurocysticercosis is the most common parasitic infection of the central nervous system." | 1.33 | Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. ( Bouldin, A; Pinter, JD, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (42.00) | 29.6817 |
| 2010's | 26 (52.00) | 24.3611 |
| 2020's | 3 (6.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reid, MM | 1 |
| Obenaus, A | 2 |
| Mukherjee, PK | 1 |
| Khoutorova, L | 2 |
| Roque, CR | 1 |
| Petasis, NA | 2 |
| Oria, RB | 1 |
| Belayev, L | 2 |
| Bazan, NG | 2 |
| Zhao, D | 1 |
| Chen, X | 1 |
| Wang, R | 1 |
| Pang, H | 1 |
| Wang, J | 1 |
| Liu, L | 1 |
| Zheng, Y | 1 |
| Lieschke, F | 1 |
| Schaefer, JH | 1 |
| Wang, X | 1 |
| Foerch, C | 1 |
| van Leyen, K | 1 |
| Ball, STE | 1 |
| Taylor, R | 1 |
| McCollum, CN | 1 |
| Erdogan, M | 1 |
| Senadim, S | 1 |
| Ince Yasinoglu, KN | 1 |
| Selcuk, HH | 1 |
| Atakli, HD | 1 |
| Diestro, JDB | 1 |
| Regaldo, JJH | 1 |
| Gonzales, EM | 1 |
| Dorotan, MKC | 1 |
| Espiritu, AI | 1 |
| Pascual, JLR | 1 |
| Rahmani, MR | 1 |
| Shamsizadeh, A | 1 |
| Moghadam-Ahmadi, A | 1 |
| Kaeidi, A | 1 |
| Allahtavakoli, M | 1 |
| Berchie, PO | 1 |
| Sarfo, FS | 1 |
| Opare-Sem, OK | 1 |
| Ovbiagele, B | 1 |
| Shamsara, A | 1 |
| Sheibani, V | 1 |
| Asadi-Shekaari, M | 1 |
| Nematollahi-Mahani, SN | 1 |
| Zhao, R | 1 |
| Feng, XY | 1 |
| Zhang, M | 1 |
| Shen, XL | 1 |
| Su, JJ | 1 |
| Liu, JR | 1 |
| Kumako, V | 1 |
| Derex, L | 1 |
| Blanc-Lasserre, K | 1 |
| Beschet, A | 1 |
| Benhamouda, H | 1 |
| Nighoghossian, N | 1 |
| Wang, Z | 1 |
| Huang, W | 1 |
| Zuo, Z | 1 |
| Toda, Y | 1 |
| Katsura, K | 1 |
| Saito, M | 1 |
| Inaba, T | 1 |
| Sakurazawa, M | 1 |
| Katayama, Y | 1 |
| Shi, HQ | 1 |
| Zhang, Y | 1 |
| Cheng, MH | 1 |
| Fan, BS | 1 |
| Tian, JS | 1 |
| Yu, JG | 1 |
| Chen, B | 1 |
| Ahmad, MA | 1 |
| Najmi, AK | 1 |
| Mujeeb, M | 1 |
| Akhtar, M | 2 |
| Kim, SW | 2 |
| Choi, KJ | 1 |
| Park, JY | 1 |
| Yoon, SH | 3 |
| Lee, JK | 2 |
| Leung, TW | 1 |
| Yu, SC | 1 |
| Lam, WW | 1 |
| Chan, AY | 1 |
| Lau, AY | 1 |
| Wong, LK | 1 |
| Gao, F | 1 |
| Jiang, WJ | 1 |
| Laalou, FZ | 1 |
| Kuntzmann, H | 1 |
| Mahoudeau, G | 1 |
| Kremer, S | 1 |
| Pain, L | 1 |
| Jeong, JY | 1 |
| Kim, HJ | 1 |
| Seo, JS | 1 |
| Han, PL | 1 |
| Albanese, A | 1 |
| Esposito, G | 1 |
| Puca, A | 1 |
| Tuttolomondo, A | 1 |
| Tirpakova, B | 1 |
| Di Giuda, D | 1 |
| Maira, G | 1 |
| Di Lazzaro, V | 1 |
| Sallustio, F | 1 |
| Di Legge, S | 1 |
| Rossi, C | 1 |
| Stanzione, P | 1 |
| Pratap, R | 1 |
| Pillai, KK | 1 |
| Khanam, R | 1 |
| Islam, F | 1 |
| Ahmad, SJ | 1 |
| Venker, C | 1 |
| Stracke, P | 1 |
| Berlit, P | 1 |
| Diehl, RR | 1 |
| Kurre, W | 1 |
| Sorgenfrei, U | 1 |
| Krämer, M | 1 |
| Chapot, R | 1 |
| Mokin, M | 1 |
| Darkhabani, Z | 1 |
| Binning, MJ | 1 |
| Levy, EI | 1 |
| Siddiqui, AH | 1 |
| Pirker, S | 1 |
| Baumgartner, C | 1 |
| Malferrari, G | 1 |
| Zedde, M | 1 |
| De Berti, G | 1 |
| Maggi, M | 1 |
| Marcello, N | 1 |
| Muñiz, AE | 1 |
| Eady, TN | 1 |
| Atkins, KD | 1 |
| Hong, S | 1 |
| Lu, Y | 1 |
| Zhang, C | 1 |
| Jun, B | 1 |
| Fredman, G | 1 |
| Zhu, M | 1 |
| Winkler, JW | 1 |
| Serhan, CN | 1 |
| Stanley, A | 1 |
| Candy, S | 1 |
| Levin, C | 1 |
| Heckmann, JM | 1 |
| Al-Atassi, T | 1 |
| Lam, K | 1 |
| Forgie, M | 1 |
| Boodhwani, M | 1 |
| Rubens, F | 1 |
| Hendry, P | 1 |
| Masters, R | 1 |
| Goldstein, W | 1 |
| Bedard, P | 1 |
| Mesana, T | 1 |
| Ruel, M | 1 |
| Miao, Z | 1 |
| Jiang, L | 1 |
| Wu, H | 1 |
| Bao, Y | 1 |
| Jiao, L | 1 |
| Li, S | 1 |
| Wu, J | 1 |
| Hua, Y | 1 |
| Li, Y | 1 |
| Zhu, J | 1 |
| Zhu, F | 1 |
| Liu, X | 1 |
| Ling, F | 1 |
| Uddin, G | 1 |
| Hussain, M | 1 |
| Wang, CX | 1 |
| Todd, KG | 1 |
| Shuaib, A | 1 |
| Matsui, M | 1 |
| Tomimoto, H | 1 |
| Sano, K | 1 |
| Hashikawa, K | 1 |
| Fukuyama, H | 1 |
| Shibasaki, H | 1 |
| Lucivero, V | 1 |
| Mezzapesa, DM | 1 |
| Petruzzellis, M | 1 |
| Carella, A | 1 |
| Lamberti, P | 1 |
| Federico, F | 1 |
| Inoue, A | 1 |
| Fukumoto, SY | 1 |
| Kumon, Y | 1 |
| Watanabe, H | 1 |
| Fumoto, N | 1 |
| Oda, S | 1 |
| Ohue, S | 1 |
| Ohnishi, T | 1 |
| Kwon, SU | 1 |
| Cho, YJ | 1 |
| Koo, JS | 1 |
| Bae, HJ | 1 |
| Lee, YS | 1 |
| Hong, KS | 1 |
| Lee, JH | 1 |
| Kim, JS | 1 |
| Buhk, JH | 1 |
| Wellmer, A | 1 |
| Knauth, M | 1 |
| Rougeot, C | 1 |
| Boissier, C | 1 |
| Chabrier, S | 1 |
| Khalifeh, MR | 1 |
| Redett, RJ | 1 |
| Gwag, BJ | 1 |
| Lee, YA | 1 |
| Ko, SY | 1 |
| Lee, MJ | 1 |
| Im, DS | 1 |
| Yun, BS | 1 |
| Lim, HR | 1 |
| Park, SM | 1 |
| Byun, HY | 1 |
| Son, SJ | 1 |
| Kwon, HJ | 1 |
| Lee, JY | 1 |
| Cho, JY | 1 |
| Won, SJ | 1 |
| Kim, KW | 1 |
| Ahn, YM | 1 |
| Moon, HS | 1 |
| Lee, HU | 1 |
| Noh, JH | 1 |
| Chung, JM | 1 |
| Cho, SI | 1 |
| Bouldin, A | 1 |
| Pinter, JD | 1 |
| Topakian, R | 1 |
| Nussbaumer, K | 1 |
| Trenkler, J | 1 |
| Aichner, FT | 1 |
| Jeon, HW | 1 |
| Cha, JK | 1 |
| Briyal, S | 1 |
| Gulati, A | 1 |
| Gupta, YK | 1 |
| Agrawal, A | 1 |
| Joharapurkar, SR | 1 |
| Gharde, P | 1 |
| Zheng, Z | 1 |
| Schwab, S | 1 |
| Grau, A | 1 |
| Berger, C | 1 |
| Kawano, KI | 1 |
| Fujishima, K | 1 |
| Ikeda, Y | 1 |
| Kondo, K | 1 |
| Umemura, K | 1 |
| Legos, JJ | 1 |
| Mangoni, AA | 1 |
| Read, SJ | 1 |
| Campbell, CA | 1 |
| Irving, EA | 1 |
| Roberts, J | 1 |
| Barone, FC | 1 |
| Parsons, AA | 1 |
| Cintas, P | 1 |
| Le Traon, AP | 1 |
| Larrue, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Platelet Function and Neurological Events Following Carotid Thromboendarterectomy[NCT05572320] | 386 participants (Anticipated) | Observational | 2022-10-10 | Recruiting | |||
| Study of the Efficacy and Safety of Cilostazol in the Prevention of Ischemic Vascular Events in Diabetic Patients With Symptomatic Peripheral Artery Disease.[NCT02983214] | Phase 4 | 826 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| [NCT00222040] | Phase 2 | 20 participants (Actual) | Interventional | 2004-06-30 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for aspirin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
[Cerebral infarction after ovarian hyperstimulation in the era of thrombolysis].
Topics: Adult; Aspirin; Craniotomy; Drug Therapy, Combination; Fatal Outcome; Female; Fibrinolytic Agents; H | 2014 |
The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Damage, | 2006 |
4 trials available for aspirin and Infarction, Middle Cerebral Artery
44 other studies available for aspirin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window.
Topics: Animals; Aspirin; Infarction, Middle Cerebral Artery; Ischemic Stroke; Male; Neuroprotection; Neurop | 2022 |
Determining the chemical profile of Caragana jubata (Pall.) Poir. by UPLC-QTOF-MS analysis and evaluating its anti-ischemic stroke effects.
Topics: Animals; Aspirin; Brain Ischemia; Caragana; Infarction, Middle Cerebral Artery; Ischemic Stroke; Pla | 2023 |
Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke.
Topics: Animals; Aspirin; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Drug Therapy, Combinatio | 2019 |
Resistance to Antiplatelet Therapy Is Associated With Symptoms of Cerebral Ischemia in Carotid Artery Disease.
Topics: Aspirin; Carotid Artery Diseases; Clopidogrel; Drug Resistance; Female; Humans; Infarction, Middle C | 2020 |
Internal Carotid Artery Agenesis with an Intercavernous Anastomosis: A Rare Case.
Topics: Angiography, Digital Subtraction; Anticoagulants; Arteriovenous Anastomosis; Aspirin; Carotid Artery | 2017 |
Cor triatriatum and stroke.
Topics: Adult; Anticoagulants; Aspirin; Cor Triatriatum; Echocardiography; Fatal Outcome; Female; Heart Atri | 2017 |
Monoacylglycerol lipase inhibitor, JZL-184, confers neuroprotection in the mice middle cerebral artery occlusion model of stroke.
Topics: Animals; Aspirin; Behavior, Animal; Benzodioxoles; Brain; Brain Edema; Brain Ischemia; Disease Model | 2018 |
Recurrent Stroke in a Ghanaian Patient With Polycythemia.
Topics: Aphasia, Broca; Aspirin; Clopidogrel; Ghana; Humans; Hydroxyurea; Infarction, Middle Cerebral Artery | 2019 |
Neural like cells and acetyl-salicylic acid alter rat brain structure and function following transient middle cerebral artery occlusion.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Cell Differentiation; Cells, Cultured; Humans; Infarctio | 2018 |
Progressive hemorrhagic transformation following dual antiplatelet therapy.
Topics: Angiography, Digital Subtraction; Aspirin; Brain; Cerebral Angiography; Cerebral Hemorrhage; Clopido | 2014 |
Perioperative aspirin improves neurological outcome after focal brain ischemia possibly via inhibition of Notch 1 in rat.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Infarction; D | 2014 |
The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat.
Topics: Aldehydes; Animals; Aspirin; bcl-2-Associated X Protein; Brain; Cilostazol; Cyclooxygenase 2; Drug T | 2014 |
Sodium Sulfide, a Hydrogen Sulfide-Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats.
Topics: Acute Disease; Analysis of Variance; Animals; Apoptosis; Aspirin; Blood Pressure; Cell Survival; Cel | 2016 |
Protective Effect of Guggulipid in High Fat Diet and Middle Cerebral Artery Occlusion (MCAO) Induced Ischemic Cerebral Injury in Rats.
Topics: Animals; Aspirin; Atorvastatin; Brain; Brain Ischemia; Catalase; Commiphora; Diet, High-Fat; Drug Th | 2016 |
Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Brain; Brain Ischemia; Cytokines; Infarction, Middle Cer | 2017 |
Would self-expanding stent occlude middle cerebral artery perforators?
Topics: Adult; Aged; Angioplasty; Aspirin; Clopidogrel; Female; Follow-Up Studies; Humans; Infarction, Middl | 2009 |
Transient ischemic attack associated with stenosis of accessory middle cerebral artery: a case report.
Topics: Aphasia; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Humans; Hypertension; | 2009 |
[Postoperative ischemic acute stroke and thrombolytic therapy].
Topics: Acute Disease; Aged; Anticoagulants; Aphasia, Broca; Aspirin; Cholesteatoma; Ear Diseases; Ear, Exte | 2009 |
Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Topics: Animals; Aspirin; Astringents; Astrocytes; Brain Infarction; Cells, Cultured; Cerebral Cortex; Cytok | 2010 |
Positional brain ischemia with MCA occlusion successfully treated with extra-intracranial bypass.
Topics: Aspirin; Cerebral Revascularization; Clopidogrel; Humans; Infarction, Middle Cerebral Artery; Ischem | 2010 |
Ultrasound evaluation of early changes in arterial dissection.
Topics: Aspirin; Blood Proteins; Carotid Artery, Internal; Carotid Artery, Internal, Dissection; Cerebrovasc | 2010 |
Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Aspirin; Biphenyl Compounds; Brain I | 2011 |
[New options in the therapeutic management of acute ischaemic stroke. Good results with combined i. v. and i. a. lysis and mechanical thrombectomy].
Topics: Acute Disease; Adult; Aged; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebral Angiography; | 2010 |
Small unruptured partially thrombosed aneurysms and stroke: report of three cases and review of the literature.
Topics: Aspirin; Atorvastatin; Craniotomy; Echocardiography, Transesophageal; Fibrinolytic Agents; Heptanoic | 2012 |
Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil.
Topics: Aged, 80 and over; Anticonvulsants; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1 | 2011 |
An unexpected evolution of symptomatic mild middle cerebral artery (MCA) stenosis: asymptomatic occlusion.
Topics: Adult; Aphasia; Aspirin; Clopidogrel; Female; Humans; Infarction, Middle Cerebral Artery; Magnetic R | 2011 |
Thrombolytic therapy for acute stroke in a teenager.
Topics: Adolescent; Aspirin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cerebral Angiography; Defibril | 2012 |
Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Docosahexaenoic Acids; In | 2012 |
The complexity of HIV vasculopathy.
Topics: Adult; Aspirin; Cytomegalovirus Infections; Female; HIV Infections; Humans; Infarction, Middle Cereb | 2012 |
Acetylsalicylic acid reduces perfusion deficit in ischemic injured brain in rats.
Topics: Animals; Aspirin; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Fibrinolytic | 2003 |
Paroxysmal dysarthria and ataxia after midbrain infarction.
Topics: Aged; Anticoagulants; Aspirin; Cerebellum; Diplopia; Dysarthria; Gait Ataxia; Humans; Infarction, Mi | 2004 |
Ischaemic stroke in progressive systemic sclerosis.
Topics: Aspirin; Brain Ischemia; Dysarthria; Female; Humans; Infarction, Middle Cerebral Artery; Magnetic Re | 2004 |
[A case of common carotid artery dissection showing remission in short-term].
Topics: Antipyrine; Aortic Dissection; Aspirin; Carotid Artery Diseases; Carotid Artery, Common; Drug Therap | 2005 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2006 |
Post-varicella arteriopathy: benefits of using serial transcranial Doppler examinations.
Topics: Aphasia; Aspirin; Cerebral Arterial Diseases; Chickenpox; Child, Preschool; Hemiplegia; Humans; Infa | 2006 |
Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine.
Topics: Animals; Antioxidants; Aspirin; Benzoates; Brain Ischemia; Cells, Cultured; Excitatory Amino Acid An | 2007 |
Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Chorea; Gadoliniu | 2006 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2007 |
Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; D | 2008 |
Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
Topics: Animals; Antioxidants; Aspirin; Brain Ischemia; Disease Models, Animal; Drug Therapy, Combination; E | 2007 |
Ischemic stroke in a child mistaken as functional disorder.
Topics: Adolescent; Aspirin; Chronic Disease; Diagnostic Errors; Diffusion Magnetic Resonance Imaging; Dysar | 2007 |
Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin.
Topics: Acute Disease; Animals; Aspirin; Brain; Brain Damage, Chronic; Dose-Response Relationship, Drug; Dru | 2007 |
ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Topics: Amides; Animals; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cerebrovascular Circulation; F | 2000 |
Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 2002 |